Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancer

19 Aug 2024

Abstract excerpt

BACKGROUND: Gastric cancer (GC) is a type of cancer with high incidence and mortality rates. Although various chemical interventions are being developed to treat gastric cancer, there is a constant demand for research into new GC treatment targets and modes of action (MOAs) because of the low effectiveness and side effects of current treatments. METHODS: Using the TCGA data portal, we identified EHMT2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39160629
DOI: 10.1186/s40164-024-00554-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancerPMID 39160629Read ↗

RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.Semantic proximity Read ↗

TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome.Semantic proximity Read ↗

NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.Semantic proximity Read ↗

Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer.Semantic proximity Read ↗

The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.Semantic proximity Read ↗

TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).Semantic proximity Read ↗

Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancerSemantic proximity Read ↗

HJURP modulates cell proliferation and chemoresistance via the MYC/TOP2A transcriptional axis in gastric cancerSemantic proximity Read ↗

The Curcumin Analog Da0324 Inhibits the Proliferation of Gastric Cancer Cells Via HOTAIRM1/miR-29b-1-5p/PHLPP1 AxisSemantic proximity Read ↗

PRMT1-Catalyzed NUSAP1 Methylation Enhances Notch2 Signaling and 5-FU Resistance in Gastric CancerSemantic proximity Read ↗

Alteration of gene expression and DNA methylation in drug-resistant gastric cancerSemantic proximity Read ↗

PI3 expression predicts recurrence after chemotherapy with DNA ‐damaging drugs in gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.